Heartbeat-Synced music therapy tested for MS pain relief
NCT ID NCT06800144
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 2 times
Summary
This study tests whether listening to music or metronome sounds that match your heart rate can reduce chronic pain in people with multiple sclerosis. 45 participants will be split into three groups: one does motor imagery with a heartbeat-synced metronome, one listens to relaxing music synced to their heartbeat, and one continues usual care. All sessions are done at home via video calls over 8 weeks, and researchers will measure pain, fatigue, mood, sleep, and heart rate changes.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- heart rate-synchronized music therapy and motor imagery training
- What this could lead to
- If it works, this could offer a non-drug, home-based way to reduce chronic pain and improve mood, sleep, and quality of life for people with MS.
- What could go wrong
- This is a small, early-stage trial with only 45 participants, so results may not apply to everyone. The therapy is behavioral, so effects may be modest and require consistent participation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
45 people
The number who actually took part.
- Started
-
Mar 2026
- Finished
-
Aug 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Being between the ages of 18-65. * Having a definite MS diagnosis according to the 2017 McDonald criteria. * Having a pain level of at least 3 and above on the numerical pain scale for at least 3 months. * Not having had an attack in the last 3 months. * Having a tablet or computer with an active internet connection that is suitable for videoconferencing. * Having a smartphone to which the heart rate monitor can be connected with the Bluetooth feature so that the heart rate synchronized music therapy training can be given. * Having sufficient smartphone/tablet or computer knowledge to participate in the study or having a relative who can help in this regard. * No change in the medications used for pain in the last 2 months. * Not receiving any additional treatment other than routine treatments. * Being able to read and understand Turkish. Exclusion Criteria: * Having a serious musculoskeletal, cardiovascular, pulmonary, metabolic or other disease that would prevent participation in the study. * Having a condition other than MS that can cause pain, such as cancer, diabetes, significant osteoarthritis or rheumatoid arthritis, based on laboratory or imaging findings * Having a psychiatric disease (such as active psychotic disorders, severe depression, anxiety disorders) that would prevent participation in the study and having a serious cognitive disorder determined by a physician that would prevent testing * Having a serious vision or hearing problem. * Being pregnant.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Multiple sclerosis (MS) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Istanbul Bilgi University
Istanbul, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single injection tame stubborn multiple sclerosis?
- Could a gentle zapping of the brain ease MS fatigue and brain fog?
- Engineered immune cells take aim at autoimmune diseases
- Can an extra shot boost COVID protection in autoimmune patients?
- CAR-T therapy targets autoimmune diseases, but trial never started
- Nurse-Led video calls aim to empower MS patients